Patent

Compounds and method for alleviating angiotensin related hypertension

E. R. Squibb & Sons, Inc.

US 4,053,651GrantedGranted Oct 11, 1977Filed May 10, 1976

A method for alleviating or reducing angiotensin related hypertension in hypertensive mammals comprises administering to such hypertensive mammals an effective amount of an angiotensin converting enzyme inhibitor selected from a group of mercaptoacyl aminoacids.

Claims
11
1 independent claim
Filing to grant
1.4 years
Pendency

1ClaimsFirst of 11

  1. 1

    A method for alleviating angiotensin related hypertension in hypertensive mammals which comprises administering an effective dose of an angiotensin converting enzyme inhibitor having the formula ##STR8## or salt thereof, wherein R.sub.1 is hydrogen, lower alkyl, phenyllower alkylene, hydroxy-lower alkylene, hydroxyphenyl-lower alkylene or guanidinolower alkylene; R.sub.2, R.sub.3 and R.sub.4 each is hydrogen, lower alkyl or phenyl-lower alkylene; R.sub.5 is hydrogen, lower alkanoyl, benzoyl or…

2Description

Background of the Invention

Angiotensin II is a powerful vasoconstrictor agent that has been implicated as the main causative agent in the etiology of renovascular hypertension.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API